Genomic Testing
Who is rWGS for?
rWGS is intended for critically ill infants in the NICU or PICU who need rapid diagnosis.
Patients with:
- Multiple congenital anomalies (birth defects)
- Several systems affected
- Inborn errors of metabolism
- Immunodeficiency
- Respiratory distress
- Failure to thrive
- Neurodevelopmental disorders
Whole Genome Sequencing Includes
- Intergenic "dark matter" (~90%)
- Introns (9%)
- Exonic/Coding regions (1.5%)
- Also covered by Whole Exome Sequencing
Benefits of using rWGS
Speed
Deliever large volumes of data in a short period of time
Breadth
Captures large and small variants that might otherwise be missed
Depth
Provides a high-resolutions, base-by-base view of the genome
Broaden
Identifies potential causative variants in novel/candidate genes
How can rWGS help?
rWGS is the fastest means we have of identifying these conditions for clinicians and can provide the care patients need.
- 32% of affected individuals had a change in medical care*
- Demonstrated cost savings*
FULGENT'S rWGS
- Panel Coverage:Focus on genes related to clinical notes + pre-set NICU gene list
- Gene Details:>96% of the genome @ 20x; typical average coverage @ 30-45x
- Specimen Req:Whole blood; Analysis must be run as a trio with both parents; All samples must be received at the same time
- Reporting Policy:Pathogenic and Likely Pathogenic Variants that are diagnostic
- Sequencing Methods:NGS
- Turnaround Time:7-10 days
SPECIFICATIONS
To ensure expedited processing of this test and avoid delays, please contact us at clientservices@fulgentgenetics.com for more details.